New discoveries in progressive myoclonus epilepsies: a clinical outlook

Expert Review of Neurotherapeutics
Shweta Bhat, Subramaniam Ganesh

Abstract

Progressive myoclonus epilepsies (PMEs) constitute a rare and heterogeneous group of genetic disorders with a distinctive triad of myoclonus, seizures, and progressive neurological deterioration. PMEs, even though rare, are arguably the severest form of epilepsies accounting for <1% of all epilepsies with age at onset varying from infancy to adulthood, depending on the disease. A majority are inherited as autosomal recessive traits, however rare types following autosomal dominant and mitochondrial inheritance are also present. Areas covered: This review discusses the genetics, molecular pathogenesis, and diagnosis of six major forms of PMEs, the current pharmacological interventions under practice and alternative treatment strategies. It also provides an update on the contemporary attempts, such as gene therapy, for etiological treatment of PMEs. Finally, it comments on the autophagy and lysosomal dysfunction, which has emerged as a unifying mechanism underlying the neurodegeneration in PMEs. Expert commentary: Despite the tremendous progress made in identifying the defective genes and dissecting their functional pathways, no etiological treatment is currently available. Thus, an integrated approach to personalized medicine wit...Continue Reading

References

Mar 1, 1978·Annals of Neurology·I RapinJ S O'Brien
Jun 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·R N NandaI D Melville
Jul 22, 1991·FEBS Letters·V Turk, W Bode
Jul 31, 1986·The New England Journal of Medicine·S F BerkovicL S Wolfe
Mar 1, 1985·Annals of Neurology·H S RosingK Weidenheim
Apr 1, 1982·Archives of Neurology·M Iivanainen, J J Himberg
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·P BrownC D Marsden
Sep 1, 1995·Human Molecular Genetics·J M SerratosaR S Sparkes
Nov 6, 1998·Electroencephalography and Clinical Neurophysiology·C A TassinariH Shibasaki
Feb 24, 2001·Neuropathology : Official Journal of the Japanese Society of Neuropathology·M YamadaH Takahashi
Mar 30, 2001·The Journal of Biological Chemistry·K E LukongA V Pshezhetsky
Oct 2, 2001·American Journal of Medical Genetics·A V Delgado-EscuetaK Yamakawa
Dec 12, 2001·The Journal of Biological Chemistry·Jianyong WangJack E Dixon
Dec 18, 2002·Journal of Neuropathology and Experimental Neurology·Patrick ShannonRichard M Myers
Sep 6, 2003·Nature Genetics·Elayne M ChanStephen W Scherer
Jan 7, 2005·Brain : a Journal of Neurology·Samuel F BerkovicRobyn H Wallace
Feb 16, 2005·Epilepsy & Behavior : E&B·Ebru AykutluAyşen Gökyigit
Jun 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Matthew S GentryJack E Dixon
Nov 29, 2005·Journal of Human Genetics·Subramaniam GaneshDeepti Dubey
May 4, 2006·Brain : a Journal of Neurology·Eija SiintolaJaana Tyynelä
Oct 10, 2006·Revue neurologique·P Genton
Feb 6, 2007·Biochemical and Biophysical Research Communications·Michelangelo MancusoGabriele Siciliano

❮ Previous
Next ❯

Citations

Oct 5, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sterre van der VeenMarina A J Tijssen
Dec 22, 2020·Frontiers in Genetics·Mostafa HotaitAhmad Beydoun
Mar 31, 2021·Acta neurologica Belgica·Fardin SoleimanipourMasoud Garshasbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Related Papers

Clinical Neurology and Neurosurgery
P M Callenbach, O F Brouwer
Seminars in Neurology
Reetta Kälviäinen
Current Neurology and Neuroscience Reports
Joshua M Doorn, Michael C Kruer
© 2022 Meta ULC. All rights reserved